Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.531 | 0.760 | 19 | 10285007 | missense variant | A/G | snv | 0.44 | 0.37 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.090 | 0.778 | 9 | 2005 | 2019 | ||||||
|
0.531 | 0.760 | 19 | 10285007 | missense variant | A/G | snv | 0.44 | 0.37 |
|
Cardiovascular Diseases | 0.090 | 1.000 | 9 | 2009 | 2019 | ||||||
|
0.531 | 0.760 | 19 | 10285007 | missense variant | A/G | snv | 0.44 | 0.37 |
|
Cardiovascular Diseases | 0.060 | 0.833 | 6 | 2004 | 2018 | ||||||
|
0.531 | 0.760 | 19 | 10285007 | missense variant | A/G | snv | 0.44 | 0.37 |
|
Digestive System Diseases | 0.060 | 1.000 | 6 | 2003 | 2015 | ||||||
|
0.531 | 0.760 | 19 | 10285007 | missense variant | A/G | snv | 0.44 | 0.37 |
|
Eye Diseases; Endocrine System Diseases; Cardiovascular Diseases | 0.060 | 0.500 | 6 | 2006 | 2018 | ||||||
|
0.531 | 0.760 | 19 | 10285007 | missense variant | A/G | snv | 0.44 | 0.37 |
|
Cardiovascular Diseases | 0.060 | 1.000 | 6 | 2009 | 2018 | ||||||
|
0.531 | 0.760 | 19 | 10285007 | missense variant | A/G | snv | 0.44 | 0.37 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases | 0.050 | 1.000 | 5 | 2006 | 2018 | ||||||
|
0.531 | 0.760 | 19 | 10285007 | missense variant | A/G | snv | 0.44 | 0.37 |
|
Nervous System Diseases; Cardiovascular Diseases | 0.050 | 1.000 | 5 | 2003 | 2019 | ||||||
|
0.531 | 0.760 | 19 | 10285007 | missense variant | A/G | snv | 0.44 | 0.37 |
|
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.050 | 0.600 | 5 | 2000 | 2019 | ||||||
|
0.531 | 0.760 | 19 | 10285007 | missense variant | A/G | snv | 0.44 | 0.37 |
|
Female Urogenital Diseases and Pregnancy Complications | 0.050 | 0.600 | 5 | 2003 | 2016 | ||||||
|
0.637 | 0.560 | 19 | 10284116 | missense variant | G/A | snv | 0.11 | 9.3E-02 |
|
Female Urogenital Diseases and Pregnancy Complications | 0.040 | 0.500 | 4 | 2003 | 2016 | ||||||
|
0.531 | 0.760 | 19 | 10285007 | missense variant | A/G | snv | 0.44 | 0.37 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.040 | 0.750 | 4 | 2006 | 2018 | ||||||
|
0.531 | 0.760 | 19 | 10285007 | missense variant | A/G | snv | 0.44 | 0.37 |
|
Digestive System Diseases | 0.040 | 0.750 | 4 | 2001 | 2015 | ||||||
|
0.637 | 0.560 | 19 | 10284116 | missense variant | G/A | snv | 0.11 | 9.3E-02 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases; Skin and Connective Tissue Diseases; Stomatognathic Diseases; Cardiovascular Diseases | 0.030 | 1.000 | 3 | 2001 | 2016 | ||||||
|
0.637 | 0.560 | 19 | 10284116 | missense variant | G/A | snv | 0.11 | 9.3E-02 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.030 | 1.000 | 3 | 2001 | 2016 | ||||||
|
0.531 | 0.760 | 19 | 10285007 | missense variant | A/G | snv | 0.44 | 0.37 |
|
Immune System Diseases; Nervous System Diseases | 0.030 | 0.333 | 3 | 2003 | 2018 | ||||||
|
0.531 | 0.760 | 19 | 10285007 | missense variant | A/G | snv | 0.44 | 0.37 |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.030 | 1.000 | 3 | 2013 | 2016 | ||||||
|
0.531 | 0.760 | 19 | 10285007 | missense variant | A/G | snv | 0.44 | 0.37 |
|
Digestive System Diseases; Neoplasms | 0.030 | 1.000 | 3 | 2006 | 2017 | ||||||
|
0.531 | 0.760 | 19 | 10285007 | missense variant | A/G | snv | 0.44 | 0.37 |
|
Neoplasms | 0.030 | 1.000 | 3 | 2014 | 2019 | ||||||
|
0.531 | 0.760 | 19 | 10285007 | missense variant | A/G | snv | 0.44 | 0.37 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.030 | 1.000 | 3 | 2006 | 2014 | ||||||
|
0.637 | 0.560 | 19 | 10284116 | missense variant | G/A | snv | 0.11 | 9.3E-02 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.020 | 0.500 | 2 | 2011 | 2016 | ||||||
|
0.637 | 0.560 | 19 | 10284116 | missense variant | G/A | snv | 0.11 | 9.3E-02 |
|
Skin and Connective Tissue Diseases; Immune System Diseases; Nervous System Diseases; Cardiovascular Diseases | 0.020 | 1.000 | 2 | 2000 | 2016 | ||||||
|
0.637 | 0.560 | 19 | 10284116 | missense variant | G/A | snv | 0.11 | 9.3E-02 |
|
Eye Diseases; Immune System Diseases; Endocrine System Diseases | 0.020 | < 0.001 | 2 | 2007 | 2013 | ||||||
|
0.637 | 0.560 | 19 | 10284116 | missense variant | G/A | snv | 0.11 | 9.3E-02 |
|
Digestive System Diseases; Nutritional and Metabolic Diseases | 0.020 | 1.000 | 2 | 2006 | 2008 | ||||||
|
0.637 | 0.560 | 19 | 10284116 | missense variant | G/A | snv | 0.11 | 9.3E-02 |
|
Immune System Diseases; Nervous System Diseases | 0.020 | 1.000 | 2 | 2017 | 2019 |